Home > > > Report Detail

Global Intravenous Solutions Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 16-Sep-2022
No. of pages: 104
Inquire Before Buying

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Intravenous Solutions market is projected to reach US$ 16960 million by 2028 from an estimated US$ 11750 million in 2022, at a CAGR of 6.3% during 2023 and 2028.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions.

The Intravenous Solutions market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Intravenous Solutions market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous Solutions manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Baxter

- Kelun Group

- Fresenius Kabi

- Otsuka

- ICU Medical

- Fresenius Kabi

- JW Life Science

- B. Braun Melsungen

Product Type Insights

Global markets are presented by Intravenous Solutions type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Intravenous Solutions are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Intravenous Solutions Segment by Type

- Crystalloids

- Colloids

- Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Intravenous Solutions market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Intravenous Solutions market.

Intravenous Solutions Segment by Application

- Basic IV Solutions

- Nutrient Infusion Solution

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Intravenous Solutions market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Intravenous Solutions industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Intravenous Solutions Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Intravenous Solutions Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Solutions Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Intravenous Solutions Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Solutions Market Size Estimates and Forecasts
2.1.1 Global Intravenous Solutions Revenue 2017-2028
2.1.2 Global Intravenous Solutions Sales 2017-2028
2.2 Intravenous Solutions Market Size by Region: 2022 Versus 2028
2.3 Intravenous Solutions Sales by Region (2017-2028)
2.3.1 Global Intravenous Solutions Sales by Region: 2017-2022
2.3.2 Global Intravenous Solutions Sales Forecast by Region (2023-2028)
2.3.3 Global Intravenous Solutions Sales Market Share by Region (2017-2028)
2.4 Intravenous Solutions Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Intravenous Solutions Revenue by Region: 2017-2022
2.4.2 Global Intravenous Solutions Revenue Forecast by Region (2023-2028)
2.4.3 Global Intravenous Solutions Revenue Market Share by Region (2017-2028)
3 Global Intravenous Solutions by Manufacturers
3.1 Global Top Intravenous Solutions Manufacturers by Sales
3.1.1 Global Intravenous Solutions Sales by Manufacturer (2017-2022)
3.1.2 Global Intravenous Solutions Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Intravenous Solutions Manufacturers by Revenue
3.2.1 Global Intravenous Solutions Revenue by Manufacturer (2017-2022)
3.2.2 Global Intravenous Solutions Revenue Share by Manufacturer (2017-2022)
3.3 Global Intravenous Solutions Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Intravenous Solutions Manufacturers Covered: Ranking by Revenue
3.4.2 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Intravenous Solutions Manufacturing Base Distribution, Product Type
3.5.1 Intravenous Solutions Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Intravenous Solutions Product Type
3.5.3 Date of International Manufacturers Enter into Intravenous Solutions Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Baxter
4.1.1 Baxter Corporation Information
4.1.2 Baxter Description, Business Overview
4.1.3 Baxter Intravenous Solutions Products Offered
4.1.4 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Baxter Intravenous Solutions Sales by Product in 2021
4.1.6 Baxter Intravenous Solutions Sales by Application in 2021
4.1.7 Baxter Intravenous Solutions Sales by Geographic Area in 2021
4.1.8 Baxter Recent Developments
4.2 Kelun Group
4.2.1 Kelun Group Corporation Information
4.2.2 Kelun Group Description, Business Overview
4.2.3 Kelun Group Intravenous Solutions Products Offered
4.2.4 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Kelun Group Intravenous Solutions Sales by Product in 2021
4.2.6 Kelun Group Intravenous Solutions Sales by Application in 2021
4.2.7 Kelun Group Intravenous Solutions Sales by Geographic Area in 2021
4.2.8 Kelun Group Recent Developments
4.3 Fresenius Kabi
4.3.1 Fresenius Kabi Corporation Information
4.3.2 Fresenius Kabi Description, Business Overview
4.3.3 Fresenius Kabi Intravenous Solutions Products Offered
4.3.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2021
4.3.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2021
4.3.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2021
4.3.8 Fresenius Kabi Recent Developments
4.4 Otsuka
4.4.1 Otsuka Corporation Information
4.4.2 Otsuka Description, Business Overview
4.4.3 Otsuka Intravenous Solutions Products Offered
4.4.4 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Otsuka Intravenous Solutions Sales by Product in 2021
4.4.6 Otsuka Intravenous Solutions Sales by Application in 2021
4.4.7 Otsuka Intravenous Solutions Sales by Geographic Area in 2021
4.4.8 Otsuka Recent Developments
4.5 ICU Medical
4.5.1 ICU Medical Corporation Information
4.5.2 ICU Medical Description, Business Overview
4.5.3 ICU Medical Intravenous Solutions Products Offered
4.5.4 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.5.5 ICU Medical Intravenous Solutions Sales by Product in 2021
4.5.6 ICU Medical Intravenous Solutions Sales by Application in 2021
4.5.7 ICU Medical Intravenous Solutions Sales by Geographic Area in 2021
4.5.8 ICU Medical Recent Developments
4.6 Fresenius Kabi
4.6.1 Fresenius Kabi Corporation Information
4.6.2 Fresenius Kabi Description, Business Overview
4.6.3 Fresenius Kabi Intravenous Solutions Products Offered
4.6.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2021
4.6.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2021
4.6.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2021
4.6.8 Fresenius Kabi Recent Development
4.7 JW Life Science
4.7.1 JW Life Science Corporation Information
4.7.2 JW Life Science Description, Business Overview
4.7.3 JW Life Science Intravenous Solutions Products Offered
4.7.4 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.7.5 JW Life Science Intravenous Solutions Sales by Product in 2021
4.7.6 JW Life Science Intravenous Solutions Sales by Application in 2021
4.7.7 JW Life Science Intravenous Solutions Sales by Geographic Area in 2021
4.7.8 JW Life Science Recent Development
4.8 B. Braun Melsungen
4.8.1 B. Braun Melsungen Corporation Information
4.8.2 B. Braun Melsungen Description, Business Overview
4.8.3 B. Braun Melsungen Intravenous Solutions Products Offered
4.8.4 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2017-2022)
4.8.5 B. Braun Melsungen Intravenous Solutions Sales by Product in 2021
4.8.6 B. Braun Melsungen Intravenous Solutions Sales by Application in 2021
4.8.7 B. Braun Melsungen Intravenous Solutions Sales by Geographic Area in 2021
4.8.8 B. Braun Melsungen Recent Development
5 Breakdown Data by Type
5.1 Global Intravenous Solutions Sales by Type (2017-2028)
5.1.1 Global Intravenous Solutions Sales by Type (2017-2022)
5.1.2 Global Intravenous Solutions Sales Forecast by Type (2023-2028)
5.1.3 Global Intravenous Solutions Sales Market Share by Type (2017-2028)
5.2 Global Intravenous Solutions Revenue Forecast by Type (2017-2028)
5.2.1 Global Intravenous Solutions Revenue by Type (2017-2022)
5.2.2 Global Intravenous Solutions Revenue Forecast by Type (2023-2028)
5.2.3 Global Intravenous Solutions Revenue Market Share by Type (2017-2028)
5.3 Intravenous Solutions Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Intravenous Solutions Sales by Application (2017-2028)
6.1.1 Global Intravenous Solutions Sales by Application (2017-2022)
6.1.2 Global Intravenous Solutions Sales Forecast by Application (2023-2028)
6.1.3 Global Intravenous Solutions Sales Market Share by Application (2017-2028)
6.2 Global Intravenous Solutions Revenue Forecast by Application (2017-2028)
6.2.1 Global Intravenous Solutions Revenue by Application (2017-2022)
6.2.2 Global Intravenous Solutions Revenue Forecast by Application (2023-2028)
6.2.3 Global Intravenous Solutions Revenue Market Share by Application (2017-2028)
6.3 Intravenous Solutions Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Intravenous Solutions Market Size YoY Growth 2017-2028
7.2 North America Intravenous Solutions Market Facts & Figures by Country
7.2.1 North America Intravenous Solutions Sales by Country (2017-2028)
7.2.2 North America Intravenous Solutions Revenue by Country (2017-2028)
7.3 North America Intravenous Solutions Sales by Type
7.4 North America Intravenous Solutions Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Intravenous Solutions Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Intravenous Solutions Market Facts & Figures by Region
8.2.1 Asia-Pacific Intravenous Solutions Sales by Region (2017-2028)
8.2.2 Asia-Pacific Intravenous Solutions Revenue by Region (2017-2028)
8.3 Asia-Pacific Intravenous Solutions Sales by Type
8.4 Asia-Pacific Intravenous Solutions Sales by Application
9 Europe
9.1 Europe Intravenous Solutions Market Size YoY Growth 2017-2028
9.2 Europe Intravenous Solutions Market Facts & Figures by Country
9.2.1 Europe Intravenous Solutions Sales by Country (2017-2028)
9.2.2 Europe Intravenous Solutions Revenue by Country (2017-2028)
9.3 Europe Intravenous Solutions Sales by Type
9.4 Europe Intravenous Solutions Sales by Application
10 Latin America
10.1 Latin America Intravenous Solutions Market Size YoY Growth 2017-2028
10.2 Latin America Intravenous Solutions Market Facts & Figures by Country
10.2.1 Latin America Intravenous Solutions Sales by Country (2017-2028)
10.2.2 Latin America Intravenous Solutions Revenue by Country (2017-2028)
10.3 Latin America Intravenous Solutions Sales by Type
10.4 Latin America Intravenous Solutions Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Intravenous Solutions Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Intravenous Solutions Market Facts & Figures by Country
11.2.1 Middle East and Africa Intravenous Solutions Sales by Country (2017-2028)
11.2.2 Middle East and Africa Intravenous Solutions Revenue by Country (2017-2028)
11.3 Middle East and Africa Intravenous Solutions Sales by Type
11.4 Middle East and Africa Intravenous Solutions Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Intravenous Solutions Supply Chain Analysis
12.2 Intravenous Solutions Key Raw Materials and Upstream Suppliers
12.3 Intravenous Solutions Clients Analysis
12.4 Intravenous Solutions Sales Channel and Sales Model Analysis
12.4.1 Intravenous Solutions Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Intravenous Solutions Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Intravenous Solutions Distributors
13 Market Dynamics
13.1 Intravenous Solutions Industry Trends
13.2 Intravenous Solutions Market Drivers
13.3 Intravenous Solutions Market Challenges
13.4 Intravenous Solutions Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intravenous Solutions Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Crystalloids
Table 3. Major Manufacturers of Colloids
Table 4. Major Manufacturers of Others
Table 5. Global Intravenous Solutions Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Intravenous Solutions Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Intravenous Solutions Sales by Region (2017-2022) & (M Units)
Table 8. Global Intravenous Solutions Sales Forecast by Region (2023-2028) & (M Units)
Table 9. Global Intravenous Solutions Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Intravenous Solutions Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Intravenous Solutions Sales by Manufacturer (2017-2022) & (M Units)
Table 12. Global Intravenous Solutions Sales Share by Manufacturer (2017-2022)
Table 13. Intravenous Solutions Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Intravenous Solutions Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Intravenous Solutions Price (2017-2022) & (USD/K Unit)
Table 16. Ranking of Global Top Intravenous Solutions Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Intravenous Solutions Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Intravenous Solutions by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Solutions as of 2021)
Table 19. Intravenous Solutions Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Intravenous Solutions Product Type
Table 21. Date of International Manufacturers Enter into Intravenous Solutions Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Baxter Corporation Information
Table 24. Baxter Description and Business Overview
Table 25. Baxter Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 26. Baxter Intravenous Solutions Product
Table 27. Baxter Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 28. Baxter Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 29. Baxter Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 30. Baxter Recent Development
Table 31. Kelun Group Corporation Information
Table 32. Kelun Group Description and Business Overview
Table 33. Kelun Group Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 34. Kelun Group Intravenous Solutions Product
Table 35. Kelun Group Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 36. Kelun Group Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 37. Kelun Group Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 38. Kelun Group Recent Development
Table 39. Fresenius Kabi Corporation Information
Table 40. Fresenius Kabi Description and Business Overview
Table 41. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 42. Fresenius Kabi Intravenous Solutions Product
Table 43. Fresenius Kabi Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 44. Fresenius Kabi Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 45. Fresenius Kabi Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 46. Fresenius Kabi Recent Development
Table 47. Otsuka Corporation Information
Table 48. Otsuka Description and Business Overview
Table 49. Otsuka Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 50. Otsuka Intravenous Solutions Product
Table 51. Otsuka Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 52. Otsuka Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 53. Otsuka Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 54. Otsuka Recent Development
Table 55. ICU Medical Corporation Information
Table 56. ICU Medical Description and Business Overview
Table 57. ICU Medical Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 58. ICU Medical Intravenous Solutions Product
Table 59. ICU Medical Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 60. ICU Medical Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 61. ICU Medical Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 62. ICU Medical Recent Development
Table 63. Fresenius Kabi Corporation Information
Table 64. Fresenius Kabi Description and Business Overview
Table 65. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 66. Fresenius Kabi Intravenous Solutions Product
Table 67. Fresenius Kabi Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 68. Fresenius Kabi Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 69. Fresenius Kabi Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 70. JW Life Science Corporation Information
Table 71. JW Life Science Description and Business Overview
Table 72. JW Life Science Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 73. JW Life Science Intravenous Solutions Product
Table 74. JW Life Science Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 75. JW Life Science Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 76. JW Life Science Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 77. B. Braun Melsungen Corporation Information
Table 78. B. Braun Melsungen Description and Business Overview
Table 79. B. Braun Melsungen Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2017-2022)
Table 80. B. Braun Melsungen Intravenous Solutions Product
Table 81. B. Braun Melsungen Intravenous Solutions Sales Proportion of Intravenous Solutions by Product in 2021
Table 82. B. Braun Melsungen Intravenous Solutions Sales Proportion of Intravenous Solutions by Application in 2021
Table 83. B. Braun Melsungen Intravenous Solutions Sales Proportion of Intravenous Solutions by Geographic Area in 2021
Table 84. Global Intravenous Solutions Sales by Type (2017-2022) & (M Units)
Table 85. Global Intravenous Solutions Sales Forecast by Type (2023-2028) & (M Units)
Table 86. Global Intravenous Solutions Revenue by Type (2017-2022) & (US$ Million)
Table 87. Global Intravenous Solutions Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 88. Global Intravenous Solutions Sales by Application (2017-2022) & (M Units)
Table 89. Global Intravenous Solutions Sales Forecast by Application (2023-2028) & (M Units)
Table 90. Global Intravenous Solutions Revenue by Application (2017-2022) & (US$ Million)
Table 91. Global Intravenous Solutions Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 92. North America Intravenous Solutions Sales by Country (2017-2022) & (M Units)
Table 93. North America Intravenous Solutions Sales by Country (2023-2028) & (M Units)
Table 94. North America Intravenous Solutions Revenue by Country (2017-2022) & (US$ Million)
Table 95. North America Intravenous Solutions Revenue by Country (2023-2028) & (US$ Million)
Table 96. North America Intravenous Solutions Sales by Type (2017-2022) & (M Units)
Table 97. North America Intravenous Solutions Sales by Application (2017-2022) & (M Units)
Table 98. Asia-Pacific Intravenous Solutions Sales by Region (2017-2022) & (M Units)
Table 99. Asia-Pacific Intravenous Solutions Sales by Region (2023-2028) & (M Units)
Table 100. Asia-Pacific Intravenous Solutions Revenue by Region (2017-2028) & (US$ Million)
Table 101. Asia-Pacific Intravenous Solutions Revenue by Region (2023-2028) & (US$ Million)
Table 102. Asia-Pacific Intravenous Solutions Sales by Type (2017-2022) & (M Units)
Table 103. Asia-Pacific Intravenous Solutions Sales by Application (2017-2022) & (M Units)
Table 104. Europe Intravenous Solutions Sales by Country (2017-2022) & (M Units)
Table 105. Europe Intravenous Solutions Sales by Country (2023-2028) & (M Units)
Table 106. Europe Intravenous Solutions Revenue by Country (2017-2022) & (US$ Million)
Table 107. Europe Intravenous Solutions Revenue by Country (2023-2028) & (US$ Million)
Table 108. Europe Intravenous Solutions Sales by Type (2017-2022) & (M Units)
Table 109. Europe Intravenous Solutions Sales by Application (2017-2022) & (M Units)
Table 110. Latin America Intravenous Solutions Sales by Country (2017-2022) & (M Units)
Table 111. Latin America Intravenous Solutions Sales by Country (2023-2028) & (M Units)
Table 112. Latin America Intravenous Solutions Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Intravenous Solutions Revenue by Country (2023-2028) & (US$ Million)
Table 114. Latin America Intravenous Solutions Sales by Type (2017-2022) & (M Units)
Table 115. Latin America Intravenous Solutions Sales by Application (2017-2022) & (M Units)
Table 116. Middle East and Africa Intravenous Solutions Sales by Country (2017-2022) & (M Units)
Table 117. Middle East and Africa Intravenous Solutions Sales by Country (2023-2028) & (M Units)
Table 118. Middle East and Africa Intravenous Solutions Revenue by Country (2017-2022) & (US$ Million)
Table 119. Middle East and Africa Intravenous Solutions Revenue by Country (2023-2028) & (US$ Million)
Table 120. Middle East and Africa Intravenous Solutions Sales by Type (2017-2022) & (M Units)
Table 121. Middle East and Africa Intravenous Solutions Sales by Application (2017-2022) & (M Units)
Table 122. Intravenous Solutions Key Raw Materials, Industry Status and Trend
Table 123. Intravenous Solutions Key Raw Materials and Upstream Suppliers
Table 124. Intravenous Solutions Clients Status and Trend
Table 125. Intravenous Solutions Typical Clients
Table 126. Intravenous Solutions Distributors
Table 127. Intravenous Solutions Market Trends
Table 128. Intravenous Solutions Market Drivers
Table 129. Intravenous Solutions Market Challenges
Table 130. Intravenous Solutions Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Solutions Product Picture
Figure 2. Global Intravenous Solutions Sales Market Share by Type in 2021 & 2028
Figure 3. Crystalloids Product Picture
Figure 4. Colloids Product Picture
Figure 5. Others Product Picture
Figure 6. Global Intravenous Solutions Sales Market Share by Application in 2021 & 2028
Figure 7. Basic IV Solutions Examples
Figure 8. Nutrient Infusion Solution Examples
Figure 9. Others Examples
Figure 10. Intravenous Solutions Report Years Considered
Figure 11. Global Intravenous Solutions Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Intravenous Solutions Market Size 2017-2028 (US$ Million)
Figure 13. Global Intravenous Solutions Sales 2017-2028 (M Units)
Figure 14. Global Intravenous Solutions Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Intravenous Solutions Sales Market Share Forecast by Region (2017-2028)
Figure 16. Global Intravenous Solutions Revenue Market Share by Region (2017-2028)
Figure 17. Global Intravenous Solutions Sales Share by Manufacturer in 2021
Figure 18. Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Intravenous Solutions Sales Market Share Forecast by Type (2017-2028)
Figure 20. Global Intravenous Solutions Revenue Market Share Forecast by Type (2017-2028)
Figure 21. Intravenous Solutions Average Selling Price (ASP) by Type (2017-2022) & (USD/K Unit)
Figure 22. Global Intravenous Solutions Sales Market Share Forecast by Application (2017-2028)
Figure 23. Global Intravenous Solutions Revenue Market Share Forecast by Application (2017-2028)
Figure 24. Intravenous Solutions Average Selling Price (ASP) by Application (2017-2022) & (USD/K Unit)
Figure 25. North America Intravenous Solutions Revenue 2017-2028 (US$ Million)
Figure 26. North America Intravenous Solutions Sales Market Share by Type (2017-2022)
Figure 27. North America Intravenous Solutions Sales Market Share by Application (2017-2022)
Figure 28. Asia-Pacific Intravenous Solutions Revenue 2017-2028 (US$ Million)
Figure 29. Asia-Pacific Intravenous Solutions Sales Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Intravenous Solutions Revenue Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Intravenous Solutions Sales Market Share by Type (2017-2022)
Figure 32. Asia-Pacific Intravenous Solutions Sales Market Share by Application (2017-2022)
Figure 33. Europe Intravenous Solutions Revenue Growth Rate 2017-2028 (US$ Million)
Figure 34. Europe Intravenous Solutions Sales Market Share by Country (2017-2028)
Figure 35. Europe Intravenous Solutions Revenue Market Share by Country (2017-2028)
Figure 36. Europe Intravenous Solutions Sales Market Share by Type (2017-2022)
Figure 37. Europe Intravenous Solutions Sales Market Share by Application (2017-2022)
Figure 38. Latin America Intravenous Solutions Revenue Growth Rate 2017-2028 (US$ Million)
Figure 39. Latin America Intravenous Solutions Sales Market Share by Country (2017-2028)
Figure 40. Latin America Intravenous Solutions Revenue Market Share by Country (2017-2022)
Figure 41. Latin America Intravenous Solutions Sales Market Share by Type (2017-2022)
Figure 42. Latin America Intravenous Solutions Sales Market Share by Application (2017-2022)
Figure 43. Middle East and Africa Intravenous Solutions Revenue Growth Rate 2017-2028 (US$ Million)
Figure 44. Middle East and Africa Intravenous Solutions Sales Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Intravenous Solutions Revenue Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Intravenous Solutions Sales Market Share by Type (2017-2022)
Figure 47. Middle East and Africa Intravenous Solutions Sales Market Share by Application (2017-2022)
Figure 48. Intravenous Solutions Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Intravenous Solutions Raw Materials by Region in 2021
Figure 50. Intravenous Solutions Distribution Channels
Figure 51. Global Intravenous Solutions Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 52. Global Intravenous Solutions Percentage 2017-2028: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs